Intensive Care Medicine

, Volume 37, Issue 5, pp 847–852 | Cite as

Reduced intubation rates for infants after introduction of high-flow nasal prong oxygen delivery

  • A. Schibler
  • T. M. T. Pham
  • K. R. Dunster
  • K. Foster
  • A. Barlow
  • K. Gibbons
  • J. L. HoughEmail author
Pediatric Original



To describe the change in ventilatory practice in a tertiary paediatric intensive care unit (PICU) in the 5-year period after the introduction of high-flow nasal prong (HFNP) therapy in infants <24 months of age. Additionally, to identify the patient subgroups on HFNP requiring escalation of therapy to either other non-invasive or invasive ventilation, and to identify any adverse events associated with HFNP therapy.


The study was a retrospective chart review of infants <24 months of age admitted to our PICU for HFNP therapy. Data was also extracted from both the local database and the Australian New Zealand paediatric intensive care (ANZPIC) registry for all infants admitted with bronchiolitis.


Between January 2005 and December 2009, a total of 298 infants <24 months of age received HFNP therapy. Overall, 36 infants (12%) required escalation to invasive ventilation. In the subgroup with a primary diagnosis of viral bronchiolitis (n = 167, 56%), only 6 (4%) required escalation to invasive ventilation. The rate of intubation in infants with viral bronchiolitis reduced from 37% to 7% over the observation period corresponding with an increase in the use of HFNP therapy. No adverse events were identified with the use of HFNP therapy.


HFNP therapy has dramatically changed ventilatory practice in infants <24 months of age in our institution, and appears to reduce the need for intubation in infants with viral bronchiolitis.


High-flow nasal cannula Oxygen delivery Infant 



We are grateful to the Preston James Fund and Golden Casket for support of this study.


  1. 1.
    Frey B, Shann F (2003) Oxygen administration in infants. Arch Dis Child 88:F84–F88CrossRefGoogle Scholar
  2. 2.
    Reid LM (1984) Lung growth in health and disease. Br J Dis Chest 78:113–134PubMedCrossRefGoogle Scholar
  3. 3.
    Thorsteinsson A, Werner O, Jonmarker C, Larsson A (2002) Airway closure in anesthetized infants and children: influence of inspiratory pressures and volumes. Acta Anaesthesiol Scand 46:529–536PubMedCrossRefGoogle Scholar
  4. 4.
    Klein M, Reynolds LG (1986) Relief of sleep-related oropharyngeal airway obstruction by continuous insufflation of the pharynx. Lancet 1:935–939PubMedCrossRefGoogle Scholar
  5. 5.
    Frey B, McQuillan PJ, Shann F, Freezer N (2001) Nasopharyngeal oxygen therapy produces positive end-expiratory pressure in infants. Eur J Pediatr 160:556–560PubMedCrossRefGoogle Scholar
  6. 6.
    McKiernan C, Chua LC, Visintainer PF, Allen H (2010) High flow nasal cannulae therapy in infants with bronchiolitis. J Pediatr 156:634–638PubMedCrossRefGoogle Scholar
  7. 7.
    Campbell DM, Shah PS, Shah V, Kelly EN (2006) Nasal continuous positive airway pressure from high flow cannula versus Infant Flow for preterm infants. J Perinatol 26:546–549PubMedCrossRefGoogle Scholar
  8. 8.
    Shoemaker MT, Pierce MR, Yoder BA, DiGeronimo RJ (2007) High flow nasal cannula versus nasal CPAP for neonatal respiratory disease: a retrospective study. J Perinatol 27:85–91PubMedCrossRefGoogle Scholar
  9. 9.
    Dysart K, Miller TL, Wolfson MR, Shaffer TH (2009) Research in high flow therapy: mechanisms of action. Respir Med 103:1400–1405PubMedCrossRefGoogle Scholar
  10. 10.
    Spence KL, Murphy D, Kilian C, McGonigle R, Kilani RA (2007) High-flow nasal cannula as a device to provide continuous positive airway pressure in infants. J Perinatol 27:772–775PubMedCrossRefGoogle Scholar
  11. 11.
    Wilkinson DJ, Andersen CC, Smith K, Holberton J (2008) Pharyngeal pressure with high-flow nasal cannulae in premature infants. J Perinatol 28:42–47PubMedCrossRefGoogle Scholar
  12. 12.
    Spentzas T, Minarik M, Patters AB, Vinson B, Stidham G (2009) Children with respiratory distress treated with high-flow nasal cannula. J Intensive Care Med 24:323–328PubMedCrossRefGoogle Scholar
  13. 13.
    Kubicka ZJ, Limauro J, Darnall RA (2008) Heated, humidified high-flow nasal cannula therapy: yet another way to deliver continuous positive airway pressure? Pediatrics 121:82–88PubMedCrossRefGoogle Scholar
  14. 14.
    Slater A, Shann F, McEniery J (2003) The ANZPIC registry diagnostic codes: a system for coding reasons for admitting children to intensive care. Intensive Care Med 29:271–277PubMedGoogle Scholar
  15. 15.
    Slater A, Shann F (2004) The suitability of the pediatric index of mortality (PIM), PIM2, the pediatric risk of mortality (PRISM), and PRISM III for monitoring the quality of pediatric intensive care in Australia and New Zealand. Pediatr Crit Care Med 5:447–454PubMedCrossRefGoogle Scholar
  16. 16.
    Alexander J, Tregea S, Slater A (2008) Report of the Australian and New Zealand Paediatric Intensive Care Registry. Australian and New Zealand Intensive Care Society, Carlton South, VictoriaGoogle Scholar

Copyright information

© Copyright jointly held by Springer and ESICM 2011

Authors and Affiliations

  • A. Schibler
    • 1
  • T. M. T. Pham
    • 1
  • K. R. Dunster
    • 1
  • K. Foster
    • 2
  • A. Barlow
    • 2
  • K. Gibbons
    • 3
  • J. L. Hough
    • 1
    • 3
    Email author
  1. 1.Paediatric Critical Care Research Group, Paediatric Intensive Care UnitMater Health ServicesSouth BrisbaneAustralia
  2. 2.Paediatric Intensive Care UnitMater Health ServicesSouth BrisbaneAustralia
  3. 3.Mater Medical Research InstituteMater Health ServicesSouth BrisbaneAustralia

Personalised recommendations